Epilepsy syndrome-specific anti-epileptic drug therapy for children

Lancet

Volumn 356, Issue 9242, 2000, Pages 1623-1624

  Trevathan, Edwin ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CLOBAZAM; CYTOCHROME P450; HYDROCORTISONE; PLACEBO; STIRIPENTOL; VALPROIC ACID; VIGABATRIN;

ADULT; CHILD; DRUG INDUSTRY; DRUG MECHANISM; DRUG POTENTIATION; EPILEPSY; FOCAL EPILEPSY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFANTILE SPASM; NOTE; PRIORITY JOURNAL; SEIZURE; TUBEROUS SCLEROSIS;

EID: 0034638785     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03151-2     Document Type: Note

References (10)

1. Proposal for revised classification of epilepsies and epileptic syndromes
2. Antiepileptic drug-induced worsening of seizures in children
3. Final rule. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients
4. Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial
5. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study
6. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
7. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)
8. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
9. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome
10. Lamictal (lamotrigine) monotherapy for typical absence seizures in children